Company Filing History:
Years Active: 2025
Title: Arthur James Bergman: Innovator in Fatty Liver Disease Treatment
Introduction
Arthur James Bergman is a notable inventor based in Salem, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of fatty liver disease and related disorders. His innovative approach has led to the development of a unique therapeutic method that addresses a pressing health issue.
Latest Patents
Bergman holds a patent for his invention titled "Combinations for treatment of NAFLD/NASH and related diseases." This patent describes a method for treating fatty liver disease with a therapeutically effective amount of a specific composition. The composition includes from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, along with from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Bergman is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in the field of pharmaceuticals.
Collaborations
Throughout his career, Bergman has worked alongside talented colleagues, including Neeta Balkrishan Amin and Roberto Arnaldo Calle. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in medical treatments.
Conclusion
Arthur James Bergman is a distinguished inventor whose work in treating fatty liver disease has the potential to impact many lives. His innovative methods and collaborations with esteemed colleagues underscore his dedication to advancing healthcare solutions.